LCH can affect any organ or system; however, in children it affects the MAPK (Mitogen-Activated Protein Kinase) pathway, most commonly BRAF-V600E (B-Raf proto-oncogene, serine/threonine kinase V600E mutation) and MAP2K1. Here, BRAF is linked to Langerhans cell histiocytosis.